Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study
Authors:
- Patrick GarneroPGPatrick Garnero
- Désirée HeijdeDHDésirée Heijde
- Nobuyuki MiyasakaNMNobuyuki Miyasaka
- Kazuhiko YamamotoKYKazuhiko Yamamoto
- Shinichi KawaiSKShinichi Kawai
- Tsutomu TakeuchiTTTsutomu Takeuchi
- Hideki YoshikawaHYHideki Yoshikawa
- Norihiro NishimotoNNNorihiro Nishimoto
Open Access
- 24 June 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 21 (1) , 10-15
Abstract
Our aim was to assess the ability of tocilizumab monotherapy to reduce progressive structural joint damage in rheumatoid arthritis patients at high risk of progression. This study was a subanalysis...Keywords
This publication has 15 references indexed in Scilit:
- Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trialAnnals of the Rheumatic Diseases, 2008
- Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markersArthritis & Rheumatism, 2007
- Urinary type II collagen helical peptide (HELIX‐II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritisArthritis & Rheumatism, 2005
- Presentation and analysis of data on radiographic outcome in clinical trials: Experience from the TEMPO studyArthritis & Rheumatism, 2005
- Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trialArthritis & Rheumatism, 2004
- Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo‐controlled, 52‐week trialArthritis & Rheumatism, 2004
- Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trialThe Lancet, 2004
- Infliximab and Methotrexate in the Treatment of Rheumatoid ArthritisNew England Journal of Medicine, 2000
- A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid ArthritisNew England Journal of Medicine, 2000
- How to read radiographs according to the Sharp/van der Heijde method.2000